RE: NIH Request for Information (RFI): To Solicit Input and Ideas for Roadmap Trans-NIH Strategic Initiatives

Eric,

 

That's a great idea. However, I wonder if we can make the November 17th
date?

 

Don

 

-----Original Message-----
From: public-semweb-lifesci-request@w3.org
[mailto:public-semweb-lifesci-request@w3.org] On Behalf Of Eric Neumann
Sent: Tuesday, October 31, 2006 8:23 AM
To: W3C HCLSIG
Subject: NIH Request for Information (RFI): To Solicit Input and Ideas for
Roadmap Trans-NIH Strategic Initiatives

 

 

http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-011.html

 

 

I am posting this to the HCLS group, since we may want to consider being one
of the responders to this RFI...

 

 

[Excerpt]

Request for Information 

This RFI invites input and ideas from the scientific community, health
professionals, patient advocates, and the general public on ways to:

*         address specific barriers to basic, translational, or clinical
research through development of novel tools, technologies, services, etc.

*         fill knowledge gaps that impede research across a broad spectrum
of health science .  

We invite you to submit individual ideas and/or to view the ideas that have
been submitted to date. All ideas should meet the following criteria for new
trans-NIH strategic initiatives :

Is the proposed initiative truly transforming -could it dramatically affect
how biomedical and/or behavioral research is conducted over the next decade?

Will the outcomes from the proposed initiatives synergistically promote and
advance the individual missions of the Institutes and Centers to benefit
health?

Does the proposed initiative require participation from NIH as a whole
and/or does it address an area (s) of science that does not clearly fall
within the mission of any one IC or OD program office?

Is the proposed initiative something that no other entity is likely or able
to do, and is there a public health benefit to having the results of the
research in the public domain ?

In addition to these general criteria, selection of initiatives will be
based on whether the proposed programs can either be achieved within a 5-10
year time frame or can be expected to become integrated with IC funded
research within that time frame. The selection will also take into
consideration current research funding, with the intent of stimulating
research in new or fledgling research areas that also meet all of the
criteria stated above. The ideas should not be disease specific and should
not address problems or opportunities that fall under the purview of one NIH
Institute or Center.

 





 

Eric Neumann, PhD

co-chair, W3C Healthcare and Life Sciences,

and Senior Director Product Strategy

Teranode Corporation

411 1st Avenue South, Suite 700

Seattle, WA 98104

+1 (781)856-9132

www.teranode.com